@king_ryan62 $NVAX quite a run YTD, maybe partly due to perception $bntx $pfe fast, but not good.

Reality:

- We will need initally any safe vaccine w a min efficacy to satisfy demand.

- Approval of 1st vacc helps subsequent (safety &amp; efficacy = same/better) approval via surrogate endpts.